Human epidermal growth factor receptor 2 testing in gastric carcinoma: issues related to heterogeneity in biopsies and resections*

Silver In Situ Hybridization (SISH) For Determination of HER2 Gene Status in Breast Carcinoma

(2010) Bettina G. Papouchado et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer

(2010) Julie M. Wu et al.   HUMAN PATHOLOGY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material

(2010) Anuttara Panchali Kumarasinghe et al.   PATHOLOGY

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neuAmplification

(2009) Matteo Brunelli et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer

(2009) R. E. Roses et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

HER-2 amplification is highly homogenous in gastric cancer

(2009) Andreas H. Marx et al.   HUMAN PATHOLOGY

HER-2 amplification is highly homogenous in gastric cancer

(2009) Michael Bilous et al.   HUMAN PATHOLOGY

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY

Chemotherapy for metastatic gastric cancer: past, present, and future

(2008) Atsushi Ohtsu   JOURNAL OF GASTROENTEROLOGY